You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Novo Nordisk shares fall 6.3% after latest trial results for its next-generation weight loss drug ○

found 2025 › Mar › 10 (Mon) @ 12:54 UTC

a story from CNBC ⚠️ › Europe News

○ Neutral overall

0.00 negativity

0.00 neutrality

0.00 positivity